Stoke Therapeutics Inc (NASDAQ:STOK)

14.18
Delayed Data
As of 4:01pm ET
 -1.64 / -10.37%
Today’s Change
12.59
Today|||52-Week Range
41.60
-40.89%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2017

2018

--

--
Revenue and IncomeNet Revenues0.000.00------
Depreciation And Amortization113.0K214.0K----
 
 
 
 
Operating ExpensesGross Income-113.0K-214.0K----
 
 
 
General Expenses5.4M12.6M----
 
 
 
Research And Development3.5M8.2M----
 
 
 
Total Operating Expenses5.5M12.8M----
 
 
 
 
Non-Operating ExpensesOperating Income-5.5M-12.8M----
 
 
 
Interest Expense On Debt21.0K0.00----
 
 
Other Expenses-4.0K-10.0K----
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.6M-12.5M----
 
 
 
Net Income-5.6M-12.5M----
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS31.3M31.3M----
 
 
 
Shares To Calculate EPS Diluted31.3M31.3M----
 
 
 
 
Earnings Per ShareEPS-$0.18-$0.40----
 
 
 
EPS Diluted-$0.18-$0.40----